Remove 2008 Remove Communication Remove Labelling
article thumbnail

FDA-Approved Labeling: Is Enough Enough?

The FDA Law Blog

Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts.

article thumbnail

Citalopram interactions to avoid

The Checkup by Singlecare

Hailing from the selective serotonin-reuptake inhibitor ( SSRI ) class of drugs, citalopram is often used for the treatment of major depressive disorder or off-label use treating anxiety disorder. These communication efforts can make all the difference. For all the good work that it does, citalopram also has its downsides.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

The FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. By Karla L. 829(e); and 2) the modified registration requirement for online pharmacies. 21 U.S.C. § 21 U.S.C. § 802(54)(D)(i).

article thumbnail

Sertraline interactions to avoid

The Checkup by Singlecare

In addition, sertraline is prescribed for several other off-label indications, including binge eating disorder and body dysmorphic disorder, even sexual dysfunction conditions like premature ejaculation. Therefore, any onset of symptoms should be managed by immediate communication with a healthcare professional.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Published June 2008. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Published June 2008. Challenges with the Current Module 2 Structure The US FDA published a white paper in 2018 calling for a revision to Module 2 because, “there can be a disconnect between applicants and regulators regarding the communication of quality data and its impact on the assessment.

article thumbnail

Root Causes of Depression and Hashimoto’s

The Thyroid Pharmacist

It breaks my heart to think about the many thyroid patients who get labeled as clinically depressed instead of being tested for thyroid antibodies, and to think of the patients who start on thyroid hormones without consideration of dosage and form, resulting in ongoing symptoms, including depression.

Dosage 122